SOBR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. SOBR is in a clear bearish trend (short/mid/long MAs stacked bearishly) and is trading near key support (~1.23). With no Intellectia buy signals, no near-term catalysts, and weakening profitability metrics despite revenue growth, the risk of further downside outweighs the upside for an impatient buyer entering immediately.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. Momentum is still negative with MACD histogram at -0.0767 (below zero), though it is negatively contracting, suggesting selling pressure may be easing but not reversing. RSI_6 is ~20.8, which is effectively oversold/washed-out and can allow for short bounces, but oversold alone is not a buy signal in a strong downtrend. Key levels: price ~1.30 sits just above S1 (1.227); a break below increases downside risk toward S2 (0.97). Resistance is heavy overhead (pivot 1.641, then R1 2.055), meaning rebounds may face selling pressure quickly.
with +136.06% YoY growth (from a small base). Technical setup is near support and oversold, which can fuel a short-term mean-reversion bounce if buyers defend ~1.
Pattern-based projection provided indicates some upside probability over 1 week/1 month (7.93% / 20.72%), but it is not a confirmed signal.
No news in the last week—no obvious event-driven catalyst to reverse the trend. Strong bearish technical structure (MA stack) increases odds that any bounce is corrective. Profitability remains weak: net income is still deeply negative (-2.19M), EPS deteriorated to -1.44 YoY, and gross margin fell materially (down ~46.78% YoY), implying worsening unit economics/efficiency. Price is close to support (1.227); failure to hold it can accelerate downside toward ~0.97.
Latest quarter: 2025/Q3. Revenue increased to 108,893 (+136.06% YoY), but the business is still very small in absolute dollars. Losses remain significant: net income was -2,186,624 (improved vs YoY by 18.76% but still highly negative). EPS dropped to -1.44 (worse YoY), and gross margin declined to 34.77 (down 46.78% YoY), indicating that growth is not translating into improved profitability and margins are compressing.
No analyst rating/price target change data was provided, so no recent trend can be confirmed. Wall Street-style pros (based on provided fundamentals): strong YoY revenue growth. Cons: very small revenue base, persistent large losses, worsening EPS and declining gross margin, and a technically bearish chart—overall skewing the pro/con balance negative right now.
